Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel
· Delayed Price · Currency is ILS · Price in ILA 888.80
-11.20 (-1.24%)
At close: Dec 4, 2025
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of 346.63 million as of December 5, 2025. Its market cap has decreased by -0.10% in one year.
Market Cap
346.63M
Enterprise Value
-89.71M
Revenue
6.62M
Ranking
n/a
PE Ratio
2.39
Stock Price
888.80
Market Cap Chart
Since March 19, 2004, Oramed Pharmaceuticals's market cap has increased from 2.37M to 346.63M, an increase of 14,517.77%. That is a compound annual growth rate of 25.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 103.27B |
| Danel (Adir Yeoshua) | 2.71B |
| Kamada | 1.32B |
| BrainsWay | 1.08B |
| Bait Bakfar | 1.04B |
| SofWave Medical | 997.78M |
| Ilex Medical | 718.16M |
| Novolog (Pharm-Up 1966) | 644.72M |